400 related articles for article (PubMed ID: 32876877)
1. Recent advances in myeloid-derived suppressor cell biology.
Yaseen MM; Abuharfeil NM; Darmani H; Daoud A
Front Med; 2021 Apr; 15(2):232-251. PubMed ID: 32876877
[TBL] [Abstract][Full Text] [Related]
2. Roles of Myeloid-Derived Suppressor Cell Subpopulations in Autoimmune Arthritis.
Li M; Zhu D; Wang T; Xia X; Tian J; Wang S
Front Immunol; 2018; 9():2849. PubMed ID: 30564242
[TBL] [Abstract][Full Text] [Related]
3. The role of myeloid-derived suppressor cells in the pathogenesis of rheumatoid arthritis; anti- or pro-inflammatory cells?
Rajabinejad M; Salari F; Gorgin Karaji A; Rezaiemanesh A
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4149-4158. PubMed ID: 31698956
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic Characterization and Isolation of Myeloid-Derived Suppressor Cells.
Reuven O; Mikula I; Ashkenazi-Preiser H; Twaik N; Ben-Meir K; Meirow Y; Daniel L; Kariv G; Kurd M; Baniyash M
Curr Protoc; 2022 Oct; 2(10):e561. PubMed ID: 36214619
[TBL] [Abstract][Full Text] [Related]
5. Anatomical Distribution of Myeloid-Derived Suppressor Cells During HIV Infection.
Yaseen MM; Abuharfeil NM; Darmani H
Viral Immunol; 2021 Dec; 34(10):673-678. PubMed ID: 34851737
[TBL] [Abstract][Full Text] [Related]
6. Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
Cantoni C; Cignarella F; Ghezzi L; Mikesell B; Bollman B; Berrien-Elliott MM; Ireland AR; Fehniger TA; Wu GF; Piccio L
Acta Neuropathol; 2017 Jan; 133(1):61-77. PubMed ID: 27704281
[TBL] [Abstract][Full Text] [Related]
7. Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
Dysthe M; Parihar R
Adv Exp Med Biol; 2020; 1224():117-140. PubMed ID: 32036608
[TBL] [Abstract][Full Text] [Related]
8. Diverse functions of myeloid-derived suppressor cells in autoimmune diseases.
Xiong X; Zhang Y; Wen Y
Immunol Res; 2024 Feb; 72(1):34-49. PubMed ID: 37733169
[TBL] [Abstract][Full Text] [Related]
9. Phytochemicals inhibit the immunosuppressive functions of myeloid-derived suppressor cells (MDSC): Impact on cancer and age-related chronic inflammatory disorders.
Salminen A; Kaarniranta K; Kauppinen A
Int Immunopharmacol; 2018 Aug; 61():231-240. PubMed ID: 29894862
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory effects of myeloid-derived suppressor cells in diseases: Role in cancer and infections.
Tamadaho RSE; Hoerauf A; Layland LE
Immunobiology; 2018; 223(4-5):432-442. PubMed ID: 29246400
[TBL] [Abstract][Full Text] [Related]
11. Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma.
Binsfeld M; Muller J; Lamour V; De Veirman K; De Raeve H; Bellahcène A; Van Valckenborgh E; Baron F; Beguin Y; Caers J; Heusschen R
Oncotarget; 2016 Jun; 7(25):37931-37943. PubMed ID: 27177328
[TBL] [Abstract][Full Text] [Related]
12. Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer.
Yamauchi Y; Safi S; Blattner C; Rathinasamy A; Umansky L; Juenger S; Warth A; Eichhorn M; Muley T; Herth FJF; Dienemann H; Platten M; Beckhove P; Utikal J; Hoffmann H; Umansky V
Am J Respir Crit Care Med; 2018 Sep; 198(6):777-787. PubMed ID: 29617574
[TBL] [Abstract][Full Text] [Related]
13. The Yin and Yang of Myeloid Derived Suppressor Cells.
Budhwar S; Verma P; Verma R; Rai S; Singh K
Front Immunol; 2018; 9():2776. PubMed ID: 30555467
[TBL] [Abstract][Full Text] [Related]
14. Role of myeloid-derived suppressor cells in autoimmune disease.
Crook KR; Liu P
World J Immunol; 2014 Mar; 4(1):26-33. PubMed ID: 25621222
[TBL] [Abstract][Full Text] [Related]
15. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential.
Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L
Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030
[TBL] [Abstract][Full Text] [Related]
16. Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment.
Qu P; Wang LZ; Lin PC
Cancer Lett; 2016 Sep; 380(1):253-6. PubMed ID: 26519756
[TBL] [Abstract][Full Text] [Related]
17. Lipid Metabolism in Tumor-Associated Myeloid-Derived Suppressor Cells.
Liu W; Song H; Li X; Ren D; Ding S; Li Y
Adv Exp Med Biol; 2021; 1316():103-115. PubMed ID: 33740246
[TBL] [Abstract][Full Text] [Related]
18. Visualization and quantification of
Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
[TBL] [Abstract][Full Text] [Related]
19. The Influence of Myeloid-Derived Suppressor Cell Expansion in Neuroinflammation and Neurodegenerative Diseases.
Tamberi L; Belloni A; Pugnaloni A; Rippo MR; Olivieri F; Procopio AD; Bronte G
Cells; 2024 Apr; 13(7):. PubMed ID: 38607083
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-Derived Suppressor Cells (MDSCs) and the Immunoinflammatory Response to Injury (Mini Review).
Sayyadioskoie SR; Schwacha MG
Shock; 2021 Nov; 56(5):658-666. PubMed ID: 33882515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
